Chromatography
Using a Specialist Detector for Nitrosamine Analysis in Pharmaceutical Drugs
Oct 10 2022
Over the past few years, the news has seen many high-profile recalls of various pharmaceutical drugs that have been found to contain nitrosamines. Nitrosamines are carcinogenic compounds, so they must be monitored to ensure unsafe levels are not found in consumer products. Governments worldwide are now requiring reporting on Nitrosamine Levels, with manufacturers often finding the analysis anything but simple, with common issues including achieving the required detection limits and false positives.
The Ellutia 800 Series TEA is the ideal detector for nitrosamine analysis thanks to its selectivity and sensitivity for Nitroso compounds. The TEA is a chemiluminescence detector that can be interfaced with a GC, HPLC, or total nitrosamine analysis system. The TEA uses a pyrolyser in GC operation to cleave the NO group from compounds as they elute from the GC column. This NO group is then reacted with ozone which produces a photon of light which is detected.
The 800 Series TEA can be interfaced with a chemical stripping system for testing pharmaceutical drugs, allowing for rapid testing of ATNC (Apparent Total N-nitrosamine content). This uses a chemical reaction to remove the NO group rather than a pyrolyser. This technique quickly gives an accurate result for the total nitrosamine content of a sample showing both volatile and non-volatile components in a single result.
Any positive sample can be further analysed by an 800 Series TEA interfaced to a GC where volatile nitrosamines such as NDMA (N-Nitrosodimethylamine) can be separated and quantified.
Learn more on how the Ellutia 800 Series TEA can help with the detection of nitrosamines in pharmaceutical drugs.
More information online
Digital Edition
Lab Asia 31.6 Dec 2024
December 2024
Chromatography Articles - Sustainable chromatography: Embracing software for greener methods Mass Spectrometry & Spectroscopy Articles - Solving industry challenges for phosphorus containi...
View all digital editions
Events
Jan 22 2025 Tokyo, Japan
Jan 22 2025 Birmingham, UK
Jan 25 2025 San Diego, CA, USA
Jan 27 2025 Dubai, UAE
Jan 29 2025 Tokyo, Japan